A multicentre phase II study of vorinostat in patients with relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma

Although initial rituximab-containing chemotherapies achieve high response rates, indolent B-cell non-Hodgkin lymphoma (B-NHL), such as follicular lymphoma (FL), is still incurable. Therefore, new effective agents with novel mechanisms are anticipated. In this multicentre phase II study, patients wi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Haematol
Main Authors: Ogura, Michinori, Ando, Kiyoshi, Suzuki, Tatsuya, Ishizawa, Kenichi, Oh, Sung Yong, Itoh, Kuniaki, Yamamoto, Kazuhito, Au, Wing Yan, Tien, Hwei-Fang, Matsuno, Yoshihiro, Terauchi, Takashi, Yamamoto, Keiko, Mori, Masahiko, Tanaka, Yoshinobu, Shimamoto, Takashi, Tobinai, Kensei, Kim, Won Seog
Formato: Artigo
Idioma:Inglês
Publicado em: BlackWell Publishing Ltd 2014
Assuntos:
Haematological Malignancy
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4282031/
https://ncbi.nlm.nih.gov/pubmed/24617454
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.12819
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados